{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:28:43Z","timestamp":1780352923314,"version":"3.54.1"},"reference-count":35,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2021,6,15]]},"abstract":"<jats:p>Background: Hypnotics, including benzodiazepines, are extensively and inappropriately prescribed for older people to treat anxiety and sleep disorders, despite the adverse health outcomes associated with their use. Objective: This study aimed to examine the association of the use of long- and short-acting hypnotics with the risk of Alzheimer\u2019s disease. Methods: Data from 234,634 participants, derived from the Korean National Health Insurance Service National Sample Cohort from 2002 to 2013, were examined. Individuals over the age of 50 years were included in the study. The dependent variable was the risk of Alzheimer\u2019s disease. Hypnotics were categorized by the period of the prescription of benzodiazepines, i.e., either till the participants were diagnosed with Alzheimer\u2019s disease or the end of the study period (December 31, 2013). Cox regression model was built to analyze the association between variables. Results: Individuals who used long-acting hypnotics were found to have a higher risk of Alzheimer\u2019s disease than non-users. Moreover, among individuals with sleep disorders, those who used hypnotics had a higher risk of Alzheimer\u2019s disease than those who did not. Conclusion: This study identified an association between the use of hypnotics and the risk of Alzheimer\u2019s disease among South Korean middle-aged and older people.<\/jats:p>","DOI":"10.3233\/jad-201319","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T15:24:37Z","timestamp":1622215477000},"page":"1381-1389","source":"Crossref","is-referenced-by-count":10,"title":["Association Between the Use of Hypnotics and the Risk of Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7334-0140","authenticated-orcid":false,"given":"Wonjeong","family":"Jeong","sequence":"first","affiliation":[{"name":"Department of Public Health, Graduate School, Yonsei University, Seoul, Republic of Korea"},{"name":"Institute of Health Services Research, Yonsei University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hong","family":"Joo","sequence":"additional","affiliation":[{"name":"Department of Public Health, Graduate School, Yonsei University, Seoul, Republic of Korea"},{"name":"Institute of Health Services Research, Yonsei University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunkyu","family":"Kim","sequence":"additional","affiliation":[{"name":"Institute of Health Services Research, Yonsei University, Seoul, Republic of Korea"},{"name":"Department of Psychiatry, Yonsei University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Kyung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Public Health, Graduate School, Yonsei University, Seoul, Republic of Korea"},{"name":"Institute of Health Services Research, Yonsei University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Cheol","family":"Park","sequence":"additional","affiliation":[{"name":"Institute of Health Services Research, Yonsei University, Seoul, Republic of Korea"},{"name":"Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-In","family":"Jang","sequence":"additional","affiliation":[{"name":"Institute of Health Services Research, Yonsei University, Seoul, Republic of Korea"},{"name":"Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-201319_ref1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12888-017-1467-z","article-title":"Trends in the prescription of benzodiazepines for the elderly in Korea","volume":"17","author":"Hwang","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.3233\/JAD-201319_ref5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.5414\/CP202008","article-title":"In-depth investigation for prescribing trends of benzodiazepines in South Korea","volume":"52","author":"Oh","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.3233\/JAD-201319_ref6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/pds.3951","article-title":"Trends in prescribing of sedative-hypnotic medications in the USA: 1993\u20132010","volume":"25","author":"Kaufmann","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.3233\/JAD-201319_ref7","doi-asserted-by":"crossref","first-page":"10071","DOI":"10.1073\/pnas.1204606109","article-title":"Loss of functional GABA a receptors in the Alzheimer diseased brain","volume":"109","author":"Limon","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-201319_ref8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/13803395.2014.928268","article-title":"The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: A systematic review and meta-analysis","volume":"36","author":"Stranks","year":"2014","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.3233\/JAD-201319_ref9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jamda.2019.08.017","article-title":"Uncertain association between benzodiazepine use and the risk of dementia: A cohort study","volume":"21","author":"Baek","year":"2020","journal-title":"J Am Med Direct Assoc"},{"key":"10.3233\/JAD-201319_ref10","doi-asserted-by":"crossref","first-page":"e0204413","DOI":"10.1371\/journal.pone.0204413","article-title":"Use of sedative-hypnotics and the risk of alzheimer\u2019s dementia: A retrospective cohort study","volume":"13","author":"Lee","year":"2018","journal-title":"PloS One"},{"key":"10.3233\/JAD-201319_ref16","doi-asserted-by":"crossref","first-page":"e6231","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: Prospective population based study","volume":"345","author":"BilliotideGage","year":"2012","journal-title":"BMJ"},{"key":"10.3233\/JAD-201319_ref17","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/jech-2011-200314","article-title":"Benzodiazepine use and risk of dementia: Evidence from the Caerphilly Prospective Study (CaPS)","volume":"66","author":"Gallacher","year":"2012","journal-title":"J Epidemiol Community Health"},{"key":"10.3233\/JAD-201319_ref18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/JGP.0b013e3181a65210","article-title":"The association between dementia and long-term use of benzodiazepine in the elderly: Nested case\u2013control study using claims data","volume":"17","author":"Wu","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-201319_ref19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000454881","article-title":"Benzodiazepine use and risk of dementia in the dlderly population: A systematic review and meta-analysis","volume":"47","author":"Islam","year":"2016","journal-title":"Neuroepidemiology"},{"key":"10.3233\/JAD-201319_ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40263-015-0305-4","article-title":"The benzodiazepine\u2013dementia disorders link: Current state of knowledge","volume":"30","author":"Pariente","year":"2016","journal-title":"CNS Drugs"},{"key":"10.3233\/JAD-201319_ref21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2165\/11534320-000000000-00000","article-title":"Quality of drug prescribing in dlderly people in nursing homes and special care units for dementia","volume":"30","author":"Olsson","year":"2010","journal-title":"Clin Drug Invest"},{"key":"10.3233\/JAD-201319_ref22","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1007\/s11096-018-0739-0","article-title":"Signal detection of benzodiazepine use and risk of dementia: Sequence symmetry analysis using South Korean national healthcare database","volume":"40","author":"Park","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"10.3233\/JAD-201319_ref23","doi-asserted-by":"crossref","first-page":"S655","DOI":"10.1016\/j.eurpsy.2017.01.1100","article-title":"Association between the use of benzodiazepines and the occurrence of acute angle-closure glaucoma in the elderly: A population-based study","volume":"41","author":"Kang","year":"2017","journal-title":"Eur Psychiatry"},{"key":"10.3233\/JAD-201319_ref24","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","article-title":"New ICD-10 version of the charlson comorbidity index predicted in-hospital mortality","volume":"57","author":"Sundararajan","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.3233\/JAD-201319_ref25","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox\u2019s regression model for counting processes: A large sample study","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann Stat"},{"key":"10.3233\/JAD-201319_ref26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jclinepi.2012.04.008","article-title":"Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias","volume":"65","author":"Wolkewitz","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"10.3233\/JAD-201319_ref27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.publhealth.20.1.145","article-title":"Time-dependent covariates in the cox proportional-hazards regression model","volume":"20","author":"Fisher","year":"1999","journal-title":"Ann Rev Public Health"},{"key":"10.3233\/JAD-201319_ref28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B"},{"key":"10.3233\/JAD-201319_ref29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/cc2955","article-title":"Statistics review 12: Survival analysis","volume":"8","author":"Bewick","year":"2004","journal-title":"Crit Care"},{"key":"10.3233\/JAD-201319_ref30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.bjc.6601118","article-title":"Survival analysis part I: Basic concepts and first analyses","volume":"89","author":"Clark","year":"2003","journal-title":"Br J Cancer"},{"key":"10.3233\/JAD-201319_ref31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0887-6177(03)00096-9","article-title":"Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: A meta-analysis","volume":"19","author":"Barker","year":"2004","journal-title":"Arch Clin Neuropsychol"},{"key":"10.3233\/JAD-201319_ref32","doi-asserted-by":"crossref","first-page":"e49113","DOI":"10.1371\/journal.pone.0049113","article-title":"Risk of dementia in patients with insomnia and long-term use of hypnotics: A population-based retrospective cohort study","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.3233\/JAD-201319_ref33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s13311-019-00801-9","article-title":"Benzodiazepines, z-hypnotics, and risk of dementia: Special considerations of half-lives and concomitant use","volume":"17","author":"Tseng","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.3233\/JAD-201319_ref34","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of alzheimer\u2019s disease: Case-control study","volume":"349","author":"DeGage","year":"2014","journal-title":"BMJ"},{"key":"10.3233\/JAD-201319_ref35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00228-007-0324-2","article-title":"Potentially inappropriate medications in the elderly: A French consensus panel list","volume":"63","author":"Laroche","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.3233\/JAD-201319_ref36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eurger.2010.01.007","article-title":"STOPP & START criteria: A new approach to detecting potentially inappropriate prescribing in old age","volume":"1","author":"O\u2019Mahony","year":"2010","journal-title":"Eur Geriatr Med"},{"key":"10.3233\/JAD-201319_ref37","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1001\/archinte.1991.00400090107019","article-title":"Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine","volume":"151","author":"Beers","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.3233\/JAD-201319_ref38","first-page":"276","article-title":"Potentially inappropriate prescribing of benzodiazepines for older adults and risk of falls during a hospital stay: A descriptive study","volume":"62","author":"Ackroyd-Stolarz","year":"2009","journal-title":"Canad J Hosp Pharm"},{"key":"10.3233\/JAD-201319_ref39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1176\/appi.ps.55.3.233","article-title":"Practical geriatrics: Use of benzodiazepines among elderly patients","volume":"55","author":"Bogunovic","year":"2004","journal-title":"Psychiatr Serv"},{"key":"10.3233\/JAD-201319_ref40","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.pnpbp.2011.03.013","article-title":"Melatonin agonists in primary insomnia and depression-associated insomnia: Are they superior to sedative-hypnotics?","volume":"35","author":"Srinivasan","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.3233\/JAD-201319_ref41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1532-5415.2010.03288.x","article-title":"Greater risk of Alzheimer\u2019s disease in older adults with insomnia","volume":"59","author":"Osorio","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-201319_ref42","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S1028-4559(10)60099-X","article-title":"Alzheimer\u2019s disease: Aging, insomnia and epigenetics","volume":"49","author":"Wu","year":"2010","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.3233\/JAD-201319_ref44","doi-asserted-by":"crossref","first-page":"543","DOI":"10.5664\/jcsm.4700","article-title":"Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: A nationwide population-based follow-up study","volume":"11","author":"Chung","journal-title":"J Clin Sleep Med"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-201319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:05:50Z","timestamp":1777370750000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-201319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":35,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-201319","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]}}}